Drug news
GSK to co pomote Testim (Auxilium Pharma) in USA
Auxilium Pharmaceuticals, and Glaxo Smith Kline have entered into an agreement to co-promote Testim (testosterone gel) testosterone replacement therapy product used in adult males. Under the terms of the agreement, Auxilium has granted GSK the exclusive right to co-promote Testim in the United States through Sept.30, 2015. GSK will promote Testim using a sizeable established field sales force which has relationships with current Testosterone Replacement Therapy prescribers, particularly primary care physicians, in the U.S.A.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins